| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 5, 2023 4:30 P.M. |
| Form: | S-1 | |||||
|
Attachments
Disclaimer
Enveric Biosciences Inc. published this content on 05 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 December 2023 11:04:24 UTC.
